March 25, 2009Convertible Term Note Amendment • May 15th, 2009 • INVO Bioscience, Inc. • Surgical & medical instruments & apparatus
This letter will evidence the agreement between you and BioXcell, Inc. (the “Company”) regarding the amendment of the Convertible Term Note dated September 18, 2008, issued to you by the Company (the “Note”).
ContractConsulting Agreement • May 15th, 2009 • INVO Bioscience, Inc. • Surgical & medical instruments & apparatus • New York
This Agreement made this February 28, 2009May 12, 2009, by and between Wakabayashi Fund, LLC., a Japanese Limited Liability Company, whose address is 4-13-20 Mita, Minato-Ku, Tokyo Japan 108-0073, hereinafter referred to as “WAKABAYASHI FUND” or “Consultant” and INVO BIOSCIENCE , a Nevada corporation, its agents, successors or assigns, hereinafter referred to as “INVO BIOSCIENCE ” OR “Client”, whose address is 100 Cummings Center, Suite 421E Beverly, MA 01915 USA Telephone No 978.878.9505; Fax No --- Symbol: IVOB.OB
